Transgene S.a Operating Margin Growth & History (TNG)
Transgene S.a's operating margin was −486.26% for fiscal 2025.
View full Transgene S.a company overviewTransgene S.a annual operating margin history
| Fiscal year | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | −486.26% | +75.02 pp |
| 2024 | 2024-12-31 | −561.28% | −180.94 pp |
| 2023 | 2023-12-31 | −380.34% | −91.25 pp |
| 2022 | 2022-12-31 | −289.10% | −53.68 pp |
| 2021 | 2021-12-31 | −235.41% | +569.45 pp |
| 2020 | 2020-12-31 | −804.86% | — |
Transgene S.a operating margin trends
Over the last five fiscal years, Transgene S.a's operating margin increased from −804.86% to −486.26%, a change of +318.61 percentage points.
What operating margin means
Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.
How operating margin is calculated
TickerStat calculates operating margin as reported operating income divided by reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Transgene S.a source filings ↗Community posts
Transgene reports €92.8 million in liquidity as vaccine development advances
Transgene ($TNG) reported €92.8 million in cash, cash equivalents and other current financial assets at its half-year end, compared with €111.9 million at the start of the year. First-half cash burn increased to €20.3 million from €18.8 mil ...